The ARC CFBD aims to advance the techniques and workflows of fragment-based drug design to establish new avenues for drug discovery. Our team have used our novel workflow called REFiL (Rapid Elaboration of Fragments into Leads) to demonstrate accelerated development of leads for drug discovery. This new method has the potential to produce a drastic … Continue reading Design in the dark – REFiL sheds light on fragment-based drug discovery
Author: arccfbd
ARC CFBD researcher awarded Early Career Research Grant by AINSE
Dr Anitha Kopinathan was awarded an Early Career Researcher Grant by The Australian Institute of Nuclear Science and Engineering (AINSE). AINSE boosts the capability of Australia and New Zealand in nuclear science, engineering and related research field by facilitating collaboration, education and training. The Early Career Researcher Grant provides a single payment of A$10,000 to … Continue reading ARC CFBD researcher awarded Early Career Research Grant by AINSE
Celebrating the official launch of ARC CFBD
Dr Narelle Tunstall, Centre Manager The Centre for Fragment-Based Design officially commenced on 22 July 2019 with the execution of our Participants Agreement and the Centre was launched by The Honourable Kevin Andrews MP on 12 November 2019. The launch was held in conjunction with Australia’s national conference on Fragment-Based Drug Design, which allowed us … Continue reading Celebrating the official launch of ARC CFBD